Search result for 'amyotrophic lateral sclerosis'

Zydus Lifesciences's Usnoflast receives Orphan Drug Designation from the USFDA for the treatment of Amyotrophic Lateral Sclerosis (ALS), a rare neurodegenerative disease.

Gland Pharma receives USFDA approval for its generic Edaravone injection, used to treat amyotrophic lateral sclerosis (ALS). The company expects to launch the product through its marketing partner...

Dr Reddy's Laboratories and Coya Therapeutics have inked a licensing agreement to develop a combination therapy for amyotrophic lateral sclerosis (ALS). The deal includes an upfront payment and...